Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06937099
Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Phase 3 · Austria, Belgium, Bulgaria, Brazil, Canada, Czechia, Germany, Denmark, Spain, France, Greece, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Puerto Rico, Romania, Slovakia, United States · 182 sites
Registry update: 4 Nov 2026
NCT06384209
Recruiting
The Friendship Bench Plus Trial
Not applicable · Zimbabwe · 1 site
Registry update: 20 Nov 2025
NCT06331468
Recruiting
Hypofractionated Radiochemotherapy
Phase 2 · United States · 1 site
Registry update: 30 Jul 2026
NCT07113522
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · Canada, Georgia, Moldova, Ukraine, United States · 54 sites
Registry update: 12 Mar 2026
NCT06992440
Recruiting
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Phase 2 · United States · 3 sites
Registry update: 13 Aug 2026
NCT07103382
Recruiting
Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
Not applicable · China · 1 site
Registry update: 5 Sept 2025
NCT06152302
Recruiting
Test of Aquatic Mobility of SMA Infants
Not applicable · France · 1 site
Registry update: 21 Nov 2025
NCT06951464
Recruiting
A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
Phase 2 · China · 1 site
Registry update: 23 Jul 2025
NCT07027254
Recruiting
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
Not applicable · South Korea · 2 sites
Registry update: 18 Jun 2025
NCT07064616
Recruiting
Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation
Not applicable · Japan · 1 site
Registry update: 26 Aug 2025
NCT06861452
Recruiting
Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
Phase 1/2 · Italy · 1 site
Registry update: 8 Sept 2026
NCT07033026
Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Phase 2 · Bulgaria, Czechia, Georgia, Hungary, South Korea, Poland, Slovakia, Taiwan, United States · 45 sites
Registry update: 1 Apr 2026
NCT06494254
Recruiting
Post-Operative Prediction of PulmonarY Function
Not applicable · Australia · 1 site
Registry update: 20 May 2026
NCT07037459
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Puerto Rico, Portugal, Romania, Sweden, Slovakia, Taiwan, United States · 684 sites
Registry update: 29 Oct 2026
NCT07285382
Recruiting
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Phase 2 · China · 2 sites
Registry update: 16 Dec 2025
NCT07264569
Recruiting
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Phase 1/2 · China · 1 site
Registry update: 4 Dec 2025
NCT07295808
Recruiting
Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)
Not applicable · France · 1 site
Registry update: 22 Dec 2025
NCT06994377
Recruiting
Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
Not applicable · Italy · 36 sites
Registry update: 17 Jun 2026
NCT07108257
Recruiting
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
Not applicable · Canada · 1 site
Registry update: 6 Aug 2025
2024-519318-30-00
Recruiting
Phase I, Open-label, Single-center, Dose Escalation Study to Assess Safety and Tolerability of anti-CD19 CAR-T Cells in Patients with B-cell non-Hodgkin Lymphomas (CARMEN).
Phase 1 · Poland · 1 site
Registry update: 13 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.